Alyami, M.H.; Musallam, A.A.; Ibrahim, T.M.; Mahdy, M.A.; Elnahas, H.M.; Aldeeb, R.A.
The Exploitation of pH-Responsive Eudragit-Coated Mesoporous Silica Nanostructures in the Repurposing of Terbinafine Hydrochloride for Targeted Colon Cancer Inhibition: Design Optimization, In Vitro Characterization, and Cytotoxicity Assessment. Pharmaceutics 2023, 15, 2677.
https://doi.org/10.3390/pharmaceutics15122677
AMA Style
Alyami MH, Musallam AA, Ibrahim TM, Mahdy MA, Elnahas HM, Aldeeb RA.
The Exploitation of pH-Responsive Eudragit-Coated Mesoporous Silica Nanostructures in the Repurposing of Terbinafine Hydrochloride for Targeted Colon Cancer Inhibition: Design Optimization, In Vitro Characterization, and Cytotoxicity Assessment. Pharmaceutics. 2023; 15(12):2677.
https://doi.org/10.3390/pharmaceutics15122677
Chicago/Turabian Style
Alyami, Mohammad H., Abeer A. Musallam, Tarek M. Ibrahim, Mahmoud A. Mahdy, Hanan M. Elnahas, and Reem A. Aldeeb.
2023. "The Exploitation of pH-Responsive Eudragit-Coated Mesoporous Silica Nanostructures in the Repurposing of Terbinafine Hydrochloride for Targeted Colon Cancer Inhibition: Design Optimization, In Vitro Characterization, and Cytotoxicity Assessment" Pharmaceutics 15, no. 12: 2677.
https://doi.org/10.3390/pharmaceutics15122677
APA Style
Alyami, M. H., Musallam, A. A., Ibrahim, T. M., Mahdy, M. A., Elnahas, H. M., & Aldeeb, R. A.
(2023). The Exploitation of pH-Responsive Eudragit-Coated Mesoporous Silica Nanostructures in the Repurposing of Terbinafine Hydrochloride for Targeted Colon Cancer Inhibition: Design Optimization, In Vitro Characterization, and Cytotoxicity Assessment. Pharmaceutics, 15(12), 2677.
https://doi.org/10.3390/pharmaceutics15122677
